Clinical Trials Directory

Trials / Sponsors / Teva Branded Pharmaceutical Products R&D LLC

Teva Branded Pharmaceutical Products R&D LLC

Industry · 16 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingAn Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
Multiple System Atrophy
Phase 22025-09-30
Active Not RecruitingA Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease
Celiac Disease
Phase 22025-03-31
CompletedA Study to Assess New Formulations of TEV-56286
Healthy Participants
Phase 12025-03-10
Active Not RecruitingA Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo
Vitiligo
Phase 12024-11-11
RecruitingA Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
Multiple System Atrophy
Phase 22024-10-02
CompletedOpen-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With S
Schizophrenia, Schizoaffective Disorder
Phase 12024-03-28
CompletedAn Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants W
Schizophrenia
Phase 12024-03-20
RecruitingA Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preven
Asthma
Phase 32023-08-30
CompletedA Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate th
Schizophrenia
Phase 32023-01-24
TerminatedA Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 1 / Phase 22023-01-23
TerminatedA Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
Multiple Myeloma
Phase 12023-01-12
Active Not RecruitingA Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Dise
Crohn Disease, Colitis, Ulcerative
Phase 22023-01-11
CompletedA Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
Migraine
Phase 32020-09-16
WithdrawnA Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therap
Relapsed and/or Refractory Multiple Myeloma
Phase 12020-06-24
TerminatedA Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced o
Neoplasms, Melanoma
Phase 1 / Phase 22019-12-12
TerminatedA Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma
Phase 1 / Phase 22017-10-04